However, Charlton et al. reported that obesity itself is an associated factor for decreased efficacy of interferon-based therapies, and they discussed the possible mechanism [34], and obesity was shown to be associated with the increased enhancement of suppressor of cytokine signaling (SOCS) family in the hepatocytes [35]. The gene discussed is CISH; the disease is obesity disorder.